In summary, we have established a GEM model of prostate cancer in which the concomitant inactivation of PTEN and P53 promotes the development of an aggressive phenotype that is characterized by accelerated tumor growth, increased invasion and development of metastatic disease that resembles late stage disease. The gene discussed is TP53; the disease is prostate cancer.